MedPath

Cortisol and Food Insecurity

Not Applicable
Recruiting
Conditions
Food Insecurity
Registration Number
NCT05191030
Lead Sponsor
University of California, Los Angeles
Brief Summary

This study will use a within-subjects design in a sample of individuals with a range of food insecurity recruited from the Los Angeles community (N = 400; 50% men). These participants will then, in counterbalanced order, be exposed to a gold-standard laboratory stressor and a control condition, one month apart. Moderation analyses will test whether cortisol reactivity to the stressor acts as a modulator of the relationship between high levels of food insecurity and increased hyperpalatable food intake.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Age 18+
  • English-speaking
Exclusion Criteria
  • Recent (<1 year) diagnosis of major psychiatric disorders including any mood disorder, schizophrenia, or PTSD
  • Recent (<1 year) diagnosis of eating disorder
  • Recent (<1 year) diagnosis of metabolic or endocrine disorder or steroid or hormonal contraceptive use
  • Pregnancy
  • Allergy to any of the foods in the food buffet
  • Participation in strict dieting or caloric restriction

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Hyperpalatable Food Intake Measured in KilocaloriesHyperpalatable food intake will be measured immediately after the intervention.

The primary outcome will be hyperpalatable food intake, initially measured in grams and converted into kilocalories. The food will consist of the following items: donuts, M\&Ms, potato chips, crackers, and Sprite. These foods were chosen because processed foods, added sugars, refined grains, starchy vegetables, and sugar sweetened beverages are foods to avoid according to the 2019 American Diabetes Association Nutrition Consensus Report and are high in carbohydrates and glycemic index.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of California, Los Angeles

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

University of California, Los Angeles
πŸ‡ΊπŸ‡ΈLos Angeles, California, United States
Alejandra Lopez, B.A.
Contact
alopez@psych.ucla.edu
David Figueroa, B.A.
Contact
dgfigueroa@psych.ucla.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.